Company Summary
Search
Home Page
 
Annidis Corporation 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
December 31TradingN
Board of Directors
NamePosition
Chunhang (Tony) Yu  Director of the Board
David Danziger  Secretary of the Board
Gerald Slemko  Director of the Board
Jinsong (Jason) Zhang  Director of the Board
Michael Crowley  Director of the Board
Michael Mueller  Chairman & Director
Ying Zhi Gu  Director of the Board
Zeljko Ribaric  President & Director
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
3/Feb/2010  Canada Ontario  
Exchange Filing Office
Location
Toronto Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Health Care and Manufacturing and Distribution of Medical Devices  About Annidis Corporation (From News Release October 4, 2013) Annidis (TSX-V: RHA) has developed and is marketing a new imaging platform technology based on Multi-Spectral Imaging (MSI). This new technology is opening a new frontier in disease identification and its management. The Annidis MSI technology allows eye-care professionals to view non-invasively the deepest areas of the eye aiding eye care professionals in the early identification and treatment of debilitating eye diseases. The Company's existing RHA 2020-U Gold, used by eye care professionals as a broad based tool for detecting early-onset of eye related diseases such as Dry AMD, has a potential market of over 20,000 clinics in North America. The RHA Platinum MD will further strengthen the value proposition allowing doctors to visualize choroidal and retinal vasculature non- invasively. The RHA Platinum MD has global market potential of more than 100,000 ophthalmologists.  
Securities
SymbolSecurity NameMarketStatus
RHAAnnidis CorporationTSX VentureTRADING
Name HistoryFromTo
Annidis Corporation13/Jun/2011Present
Company Facts Reconciliation
SubjectDate Returned
Summer 2013 CFR19/Jun/2013
Associations
Auditing Firm:  Shimmerman Penn LLP
Investor Relations:  James Binckly
Sponsor:  Canaccord Capital Corp.
Transfer Agent:  TMX Equity Transfer Services Inc.
Latest Information
TypeDateTitle
News Releases  28/Aug/2014  NEWS RELEASE - ANNIDIS CORPORATION REPORTS 2014 SECOND QUARTER RESULTS[CANADA NEWSWIRE]
    NEWS RELEASE - ANNIDIS CORPORATION ANNOUNCES ISSUANCE OF $1 000 000 REPLACEMENT NOTE AND WARRANTS[CANADA NEWSWIRE]
    NEWS RELEASE - CHINA FDA APPROVAL OF ITS RHA(TM) MULTI SPECTRAL[MARKET NEWS]
Bulletins  3/Jan/2014  Warrant Term Extension
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data